comunicato stampa
Gedeon Richter: A new hope for treatment-resistant schizophrenia?
BUDAPEST, Hungary, Oct. 5, 2023 /PRNewswire/ -- At the 23rd World Congress of Psychiatry, organized between 28 September – 1 October 2023 in Vienna, new analyses of cariprazine studies were presented by Gedeon Richter Plc. The posters provided evidence about the safety profile of cariprazine over the approved dose range as well as showed the effectiveness of cariprazine-clozapine combination for treatment-resistant schizophrenia. In addition to the e-poster presentations, Prof Christoph U. Correl...
